Preparation of particles for inhalation

Details Preparation of particles for inhalation Preparation of particles for inhalation

1997-11-17

1999-11-16

Clardy, S. Mark

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

424434, 424489, 424501, A61K 1300

Patent

active

059853093

ABSTRACT:
Particles incorporating a surfactant and/or a hydrophilic or hydrophobic complex of a positively or negatively charged therapeutic agent and a charged molecule of opposite charge for drug delivery to the pulmonary system, and methods for their synthesis and administration are provided. In a preferred embodiment, the particles are made of a biodegradable material and have a tap density less than 0.4 g/cm.sup.3 and a mass mean diameter between 5 .mu.m and 30 .mu.m, which together yield an aerodynamic diameter of the particles of between approximately one and three microns. The particles may be formed of biodegradable materials such as biodegradable polymers. For example, the particles may be formed of poly(lactic acid) or poly(glycolic acid) or copolymers thereof. Alternatively, the particles may be formed solely of a therapeutic or diagnostic agent and a surfactant. Surfactants can be incorporated on the particle surface for example by coating the particle after particle formation, or by incorporating the surfactant in the material forming the particle prior to formation of the particle. Exemplary surfactants include phosphoglycerides such as dipalmitoyl phosphatidylcholine (DPPC). The particles can be effectively aerosolized for administration to the respiratory tract to permit systemic or local delivery of wide a variety of therapeutic agents. Formation of complexes of positively or negatively charged therapeutic agents with molecules of opposite charge can allow control of the release rate of the agents into the blood stream following administration.

REFERENCES:
patent: 2470296 (1949-05-01), Fields
patent: 2533065 (1950-03-01), Taplin et al.
patent: 2992645 (1961-07-01), Fowler
patent: 3781230 (1973-12-01), Vassiliades et al.
patent: 3957965 (1976-05-01), Hartley et al.
patent: 4009280 (1977-02-01), Macarthur et al.
patent: 4089800 (1978-05-01), Temple
patent: 4161516 (1979-07-01), Bell
patent: 4173488 (1979-11-01), Vassiliades et al.
patent: 4272398 (1981-06-01), Jaffe
patent: 4352883 (1982-10-01), Lim
patent: 4391909 (1983-07-01), Lim
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4524769 (1985-06-01), Wetterlin
patent: 4572203 (1986-02-01), Feinstein
patent: 4590206 (1986-05-01), Forrester et al.
patent: 4615697 (1986-10-01), Robinson
patent: 4679555 (1987-07-01), Sackner
patent: 4741872 (1988-05-01), De Luca et al.
patent: 4743545 (1988-05-01), Torobin
patent: 4774958 (1988-10-01), Feinstein
patent: 4789550 (1988-12-01), Hommel et al.
patent: 4818542 (1989-04-01), DeLuca et al.
patent: 4847091 (1989-07-01), Illum
patent: 4855144 (1989-08-01), Leong et al.
patent: 4857311 (1989-08-01), Domb et al.
patent: 4861627 (1989-08-01), Mathiowitz et al.
patent: 4865789 (1989-09-01), Castro et al.
patent: 4904479 (1990-02-01), Illum
patent: 4917119 (1990-04-01), Potter et al.
patent: 4976968 (1990-12-01), Steiner
patent: 4994281 (1991-02-01), Muranishi et al.
patent: 5033463 (1991-07-01), Cocozza
patent: 5064065 (1991-11-01), Lew
patent: 5069936 (1991-12-01), Yen
patent: 5075109 (1991-12-01), Tice et al.
patent: 5100669 (1992-03-01), Hyon et al.
patent: 5123414 (1992-06-01), Unger
patent: 5160745 (1992-11-01), DeLuca et al.
patent: 5169871 (1992-12-01), Hughes et al.
patent: 5195520 (1993-03-01), Schlief et al.
patent: 5204108 (1993-04-01), Illum
patent: 5204113 (1993-04-01), Hartley et al.
patent: 5260306 (1993-11-01), Boardman et al.
patent: 5271961 (1993-12-01), Mathiowitz et al.
patent: 5327883 (1994-07-01), Williams et al.
patent: 5334381 (1994-08-01), Unger
patent: 5352435 (1994-10-01), Unger
patent: 5384133 (1995-01-01), Boyes et al.
patent: 5393524 (1995-02-01), Quay
patent: 5407609 (1995-04-01), Tice et al.
patent: 5456917 (1995-10-01), Wise et al.
patent: 5478578 (1995-12-01), Arnold et al.
patent: 5482946 (1996-01-01), Clark et al.
patent: 5518709 (1996-05-01), Sutton et al.
patent: 5607695 (1997-03-01), Ek et al.
patent: 5612053 (1997-03-01), Baichwal
Sela et al., "Multichain Polyamino Acids," J. Am. Chem. Soc., 78:746 (1956).
Smith, et al. "Aerosol Administration of Antibiotics" Respiration, 62(1) 19-24 (1995).
Smith, "Peptide delivery via the pulmonary route: a valid approach for local and systemic delivery" J. Contr. Rel. 46: 99-106 (1997).
Strand, et al. "Radiolabeled Colloids and Macromolecules in the Lymphatic System" Critical Reviews in Therapeutic Drug Carrier Systems 6(3): 211-238 (1989).
Swift, "The oral airway--a conduit or collector for pharmaceutical aerosols?" Respiratory Drug Delivery IV, 187-194 (1994).
Tabata et al., "Controlled Delivery Systems for Proteins Using Polyanhydride Microspheres," Pharm. Res., 10(4): 487-496 (1993).
Tabata and Ikada, "Effect of surface wettability of microspheres on phagocytosis," J. Colloid and Interface Sci., 127(1): 132-140 (1989).
Tabata and Ikada, "Macrophage Phagocytosis of Biodegradable Microspheres Composed of L-lactic Acid/Glycolic Acid Homo- and Copolymers," J. Biomed. Mater. Res., 22: 837-858 (1988).
Tabata and Ikada, "Effect of size and surface charge of polymer microspheres on their phagocytosis by macrophage," J. Biomed. Mater. Res., 22:837 (1988).
Taburet, et al. "Pharmacokinetic Optimisation of Asthma Treatment" Clin. Pharmacokinet. 26(5): 396-418 (1994).
* Tansey, "The challenges in the development of metered dose inhalation aerosols using ozone-friendly propellants," Spray Technol. Market, 4:26-29 (1994).
Timsina et al., "Drug delivery to the respiratory tract using dry powder inhalers," Int. J. Pharm., 101: 1-13 (1994).
Turner, J. and S. Hering, "Greased and oiled substrates as bounce-free impaction surfaces," J. Aerosol Sci., 18: 215-224 (1987).
* Vincent, Aerosol Science for Industrial Hygientists, Pergamon Press, NY (1995).
Visser, "An Invited Review: Van der Waals and Other Cohesive Forces Affecting Powder Fluidization," Powder Technology 58: 1-10 (1989).
Wall, "Pulmonary Absorption of Peptides and Proteins," Drug Delivery, 2:1-20 (1995).
Warheit and Hartsky, "Role of alveolar macrophage chemotaxis and phagocytosis in pulmonary clearance to inhaled particles: Comparisons among rodent species," Microscopy Res. Tech., 26: 412-422 (1993).
Wheatley, et al. "Contrast agents for diagnostic ultrasound: development and evaluation of polymer-coated microbubbles" Biomaterials 11: 713-717(1990).
* Weibel, Morphometry of the Human Lung, New York: Academic Press (1963).
Wichert, et al. Low molecular weight PLA: a suitable polymer for pulmonary administered microparticles? J. Microencapsulation, 10: 195-207 (1993).
Wong and Suslick, "Sonochemically produced hemoglobin microbubbles," Mat. Res. Soc. Symp. Proc., 372:89-95 (1995).
Zanen et al., "The optimal particle size for .beta.-adrenergic aerosols in mild asthmatics," Int. J. Pharm., 107: 211-217 (1994).
Zanen et al., "The optimal particle size for parasympathicolytic aerosols in mild asthmatics" Int. J. Pharm., 114:111-115 (1995).
Zeng, et al. "Tetrandrine delivery to the lung: The optimisation of albumin microsphere preparation by central composite design" Int. J. Pharm., 109: 135-145 (1994).
Zeng et al., "The controlled delivery of drugs to the lung," Int. J. Pharm., 124:149-164 (1995).
Adjei and Garren, "Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers," J. Pharm. Res., 7(6): 565-569 (1990).
Allen, et al. "Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection" Biochim. Biophys. Acta 1150: 9-16 (1993).
Altschuler et al., "Aerosol deposition in the human respiratory tract," Am. Med. Assoc. Arch. Indust. Health 15:293-303 (1957).
Anderson, "Human Deposition and Clearance of 6 micrometer Particles Inhaled with an Extremely Low Flow Rate" Exp. Lung Res. 21(1): 187-195 (1995).
Anderson et al., "Effect of Cystic Fibrosis on Inhaled Aerosol Boluses," Am. Rev. Respir. Dis., 140: 1317-1324 (1989).
Barrera et al., "Synthesis and RGD Peptide Modification of a New Biodegradable Copolymer: Poly(lactic acid-co-lysine)," J. Am. Chem. Soc., 115:11010 (1993).
Beck, et al., "A new Long-Acting Injectable Microcapsule System for the Ad

Affiliated with

Also associated with

Rating

Preparation of particles for inhalation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Preparation of particles for inhalation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of particles for inhalation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1320906